Showing results (1-10 of 106) with videos related to
Sort By:
Pageof 11
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2018
Glycogen Phosphorylase: A Novel Biomarker in Doxorubicin-Induced Cardiac InjuryYueming Zhu, David GiusCancer Research|April 3, 2019
Homeostatic Roles of STING in Cell Proliferation and Chromosomal InstabilityDavid Gius, Yueming ZhuThe Journal of Clinical Investigation|November 17, 2025
GSK3β guides chromosomal repair pathway selection to support BRCA1-independent PARP inhibitor sensitivityJustin W Leung, David GiusAntioxidants & Redox Signaling|August 17, 2006
Redox signaling in cancer biologyDavid Gius, Douglas R SpitzAgeing Research Reviews|November 10, 2009
Will targeting insulin growth factor help us or hurt us?: An oncologist's perspectiveMitchell Kamrava, David Gius, Giovanna Casagrande, et al.Cancer Journal (Sudbury, Mass.)|April 28, 2007
Histone deacetylase inhibitor and demethylating agent chromatin compaction and the radiation response by cancer cellsGil Bar-Sela, Kristi Muldoon Jacobs, David GiusHuman Genomics|August 3, 2011
The human sirtuin family: evolutionary divergences and functionsAthanassios Vassilopoulos, Kristofer S Fritz, Dennis R Petersen, et al.Antioxidants & Redox Signaling|July 27, 2013
Regulation of MnSOD enzymatic activity by Sirt3 connects the mitochondrial acetylome signaling networks to aging and carcinogenesisRanda Tao, Athanassios Vassilopoulos, Loukia Parisiadou, et al.Human Pathology|April 22, 2014
Decreased mitochondrial SIRT3 expression is a potential molecular biomarker associated with poor outcome in breast cancerMohamed Mokhtar Desouki, Irina Doubinskaia, David Gius, et al.Biorxiv : the Preprint Server for Biology|February 27, 2026
CNOT6 deadenylase safeguards postnatal growth and metabolic transition via <i>Fgf21</i> mRNA decayMoawiz Saeed, Mengwei Zang, David Gius, et al.Pageof 11